Fate Therapeutics Inc (FATE)
2.07
-0.15
(-6.76%)
USD |
NASDAQ |
Nov 21, 16:00
2.07
0.00 (0.00%)
Pre-Market: 08:03
Fate Therapeutics Total Assets (Quarterly): 494.97M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 494.97M |
| June 30, 2024 | 528.82M |
| March 31, 2024 | 569.89M |
| December 31, 2023 | 506.22M |
| September 30, 2023 | 543.79M |
| June 30, 2023 | 584.76M |
| March 31, 2023 | 630.34M |
| December 31, 2022 | 705.56M |
| September 30, 2022 | 749.35M |
| June 30, 2022 | 807.06M |
| March 31, 2022 | 858.39M |
| December 31, 2021 | 921.46M |
| September 30, 2021 | 984.57M |
| June 30, 2021 | 1.016B |
| March 31, 2021 | 1.046B |
| December 31, 2020 | 622.46M |
| September 30, 2020 | 626.44M |
| June 30, 2020 | 653.59M |
| March 31, 2020 | 321.89M |
| December 31, 2019 | 302.27M |
| September 30, 2019 | 340.21M |
| June 30, 2019 | 199.88M |
| March 31, 2019 | 220.86M |
| December 31, 2018 | 213.03M |
| Date | Value |
|---|---|
| September 30, 2018 | 219.95M |
| June 30, 2018 | 83.16M |
| March 31, 2018 | 93.42M |
| December 31, 2017 | 105.29M |
| September 30, 2017 | 72.68M |
| June 30, 2017 | 73.95M |
| March 31, 2017 | 85.33M |
| December 31, 2016 | 95.05M |
| September 30, 2016 | 49.30M |
| June 30, 2016 | 49.18M |
| March 31, 2016 | 58.70M |
| December 31, 2015 | 67.96M |
| September 30, 2015 | 76.40M |
| June 30, 2015 | 83.48M |
| March 31, 2015 | 44.49M |
| December 31, 2014 | 51.18M |
| September 30, 2014 | 47.01M |
| June 30, 2014 | 43.55M |
| March 31, 2014 | 49.65M |
| December 31, 2013 | 55.58M |
| September 30, 2013 | 23.04M |
| June 30, 2013 | 6.173M |
| December 31, 2012 | 11.08M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
302.27M
Minimum
Dec 2019
1.046B
Maximum
Mar 2021
673.67M
Average
628.39M
Median
Total Assets (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 3.877M |
| Palatin Technologies Inc | 3.415M |
| iBio Inc | 24.52M |
| Theriva Biologics Inc | 40.11M |
| Oragenics Inc | 5.204M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 132.64M |
| Shareholders Equity (Quarterly) | 362.33M |
| Current Ratio | 8.292 |